06.03.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />

Phar ma ceu ti cal Sales: US$ 95-100 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 55-60%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 75-80%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

90-95%<br />

Prin ci pal Prod ucts:<br />

VOVERAN (antirheumatic non-steroidal;<br />

antirheumatic top i cal; oph thal mic anti-in flam ma -<br />

tory non-steroidal)<br />

METHERGIN (la bor in ducer)<br />

TEGRITAL (antiepileptic)<br />

OTRIVIN (na sal prep a ra tion top i cal)<br />

CAL CIUM SANDOZ (cal cium prod uct)<br />

Ther a peu tic Range:<br />

anti rheu ma tics sys temic 31%<br />

min eral sup ple ments 17%<br />

gynecologicals other 11%<br />

na sal prep a ra tions 10%<br />

antiepileptics 10%<br />

Lead ing Dose Forms:<br />

coated tab lets 34%<br />

tab lets 20%<br />

liq uids 18%<br />

am poules 18%<br />

gels/sols 5%<br />

SANDOZ<br />

Full Name: Sandoz Pri vate Ltd<br />

Street Ad dress: Plot Nos. D-31 & D-32, MIDC<br />

TTC In dus trial Area Turbhe, Turbhe, Navi Mumbai<br />

400705<br />

Tel: +91 22 55910485<br />

Fax: +91 22 55910472<br />

Home Page: www.novartis.co.in<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 20-22 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 55-60%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 85-90%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

95-100%<br />

Prin ci pal Prod ucts:<br />

REGESTRONE (pro ges to gen)<br />

PZA CIBA (antitubercular prod uct)<br />

RIMACTAZID (antitubercular prod uct)<br />

FORISTAL (an ti his ta mine sys temic)<br />

CURAM (pen i cil lin broad spec trum)<br />

Ther a peu tic Range:<br />

sex hor mones sys temic 29%<br />

antibacterials sys temic 25%<br />

antimycobacterials 24%<br />

an ti his ta mines sys temic 6%<br />

antihypertensives 4%<br />

Lead ing Dose Forms:<br />

tab lets 56%<br />

coated tab lets 24%<br />

vi als 10%<br />

liq uids 7%<br />

cap sules 3%<br />

INDONESIA<br />

CIBA VI SION<br />

Full Name: PT. CIBA Vi sion Batam<br />

Street Ad dress: Jalan Beringin Kav. 204,<br />

Batamindo In dus trial Park, Mukakuning, Batam<br />

29433<br />

Tel: +62 77 0611048<br />

Fax: +62 77 0611035<br />

Home Page: www.id.novartis.com<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

HEXAL<br />

Full Name: PT Prima Hexal<br />

Street Ad dress: Wisma BSG, 5th floor, Jl.Ab dul<br />

Muis No.40, Ja karta-Pusat 10160<br />

Tel: +62 21 34834333<br />

Fax: +62 21 34834334<br />

Email: prod uct@primas-hexal.co.id<br />

Home Page: www.prima-hexal.co.id<br />

De scrip tion: De vel oper, man u fac turer, for mu la -<br />

tor, packager/as sem bler, im porter, ex porter, pro -<br />

moter, sales/detailer. Man u fac tures, ex ports for<br />

other com pa nies. Prod uct ranges in clude: phar -<br />

ma ceu ti cal prod ucts (branded, unbranded, pre -<br />

scrip tion, non-pre scrip tion), hos pi tal<br />

pharmaceuticals, di ag nos tic prod ucts, di -<br />

etetic/nu tri tional prod ucts, herbal prod ucts. Es -<br />

tab lished 1999. 526 pharmaceutical employees in<br />

2005.<br />

Rep re sen ta tives/De tail ers (Pharm, Num -<br />

ber): 281 (2005)<br />

Con tacts (Pharm): Chair man: Holger Guenzel;<br />

Com mer cial Op er a tions: Rohyat Indrawijaya;<br />

Man u fac ture: Jenny Timotiwu; Re search & De vel -<br />

op ment: Jin Nurhayati; Gen eral Con tact: Holger<br />

Guenzel<br />

Sub sid iary of: Sandoz, Ger many (94%) (group:<br />

Novartis, Swit zer land); Salutas, Ger many (6%)<br />

(group: Novartis, Swit zer land)<br />

NOVARTIS<br />

Full Name: PT. Novartis In do ne sia<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 177

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!